71186-006-35 : NDC 2026 Code

71186-006-35 : Chlordiazepoxide Hydrochloride And Clidinium Bromide ( Chlordiazepoxide Hydrochloride And Clidinium Bromide )

Additionally :

You can get information about “71186-006-35” NDC code in 71186-006-35 in HTML format

HTML | 71186-006-35 in TXT (Plain Text) format

TXT | 71186-006-35 in PDF (Portable Document Format)

PDF | 71186-006-35 in XML format

XML formats.

NDC Code : 71186-006-35 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "71186-006-35",
    "PackageDescription": "100 CAPSULE, GELATIN COATED in 1 BOTTLE (71186-006-35) ",
    "NDC11Code": "71186-0006-35",
    "ProductNDC": "71186-006",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Chlordiazepoxide Hydrochloride And Clidinium Bromide",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Chlordiazepoxide Hydrochloride And Clidinium Bromide",
    "DosageFormName": "CAPSULE, GELATIN COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20110501",
    "EndMarketingDate": null,
    "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
    "ApplicationNumber": null,
    "LabelerName": "Vilvet Pharmaceuticals Inc",
    "SubstanceName": "CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE",
    "StrengthNumber": "5; 2.5",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Benzodiazepine [EPC],Benzodiazepines [CS],Anticholinergic [EPC],Decreased Parasympathetic Acetylcholine Activity [PE],GI Motility Alteration [PE],Digestive/GI System Activity Alteration [PE],Cholinergic Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2020-08-19",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20201231",
    "StartMarketingDatePackage": "20110501",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}